Results 51 to 60 of about 1,582,509 (353)

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

, 1999
Attenuated SA14-14-2 Japanese encephalitis (JE) vaccine has been administered safely and effectively to more than 100 million children in China since 1988 and recently, licensure of the vaccine in Korea has been sought.
박민수
core   +1 more source

Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021

Nature Communications, 2022
The COVID-19 pandemic continues to impact daily life, including health system operations, despite the availability of vaccines that are effective in greatly reducing the risks of death and severe disease.
J. Lazarus, K. Wyka, Trenton M. White, C. Picchio, Kenneth H. Rabin*, S. Ratzan, Jeanna Parsons Leigh, Jia Hu, A. El-Mohandes   +8 more
semanticscholar   +1 more source

Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study [PDF]

, 2019
Rotavirus is a leading cause of severe gastroenteritis among children younger than 5 years in South Korea. Two rotavirus vaccines (RVs), pentavalent human-bovine reassortant vaccine (Rotateq®; RV5) and attenuated human strain originated monovalent ...
김지홍, 김동수
core   +1 more source

O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide

Human Vaccines & Immunotherapeutics, 2018
Staphylococcus aureus produces an antiphagocytic polysaccharide capsule to evade neutrophil-mediated killing. Many vaccines against encapsulated bacterial pathogens require generation of functional anti-capsular antibodies to mediate protection against ...
Ingrid L. Scully, Viliam Pavliak, Yekaterina Timofeyeva, Yongdong Liu, Christine Singer, Annaliesa S. Anderson   +5 more
doaj   +1 more source

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

New England Journal of Medicine, 2020
Background Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19 ...
E. Anderson, N. Rouphael, A. Widge, L. Jackson, P. Roberts, M. Makhene, J. Chappell, M. Denison, Laura J. Stevens, A. Pruijssers, A. McDermott, B. Flach, Bob C. Lin, N. Doria-Rose, O, Sijy Dell, S. Schmidt, Kizzmekia S. Corbett, P. Swanson, M. Padilla, K. Neuzil, Hamilton Bennett, B. Leav, M. Makowski, J. Albert, Kaitlyn A. Cross, V. Edara, K. Floyd, M. Suthar, David R. Martinez, R. Baric, Wendy L. Buchanan, C. Luke, Varun K. Phadke, C. Rostad, Julie E. Ledgerwood, B. Graham, J. Beigel   +37 more
semanticscholar   +1 more source

Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong

Vaccine, 2021
Background Vaccines for COVID-19 are anticipated to be available by 2021. Vaccine uptake rate is a crucial determinant for herd immunity. We examined factors associated with acceptance of vaccine based on (1). constructs of the Health Belief Model (HBM),
Martin C.S. Wong, E. Wong, Junjie Huang, A. Cheung, Kevin Law, M. K. Chong, R. Ng, C. Lai, Siaw S. Boon, J. T. Lau, Zigui Chen, P. K. Chan   +11 more
semanticscholar   +1 more source

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses

, 2008
Out of 98 subjects who had participated in the 2000 JE vaccination campaign, 69 people were enrolled in the tests of 2004 and 2005 for the evaluation of long term immune response of a single dose of live attenuated SA14-14-2 JE vaccine.
오희철
core   +1 more source

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

The Lancet, 2021
Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral response against SARS-CoV-2.
M. Tanriover, H. Doğanay, M. Akova, H. R. Güner, A. Azap, S. Akhan, Şükran Köse, F. Erdinc, E. H. Akalın, Ö. Tabak, H. Pullukçu, Özgür Batum, Serap ŞİMŞEK YAVUZ, Özge Turhan, M. T. Yıldırmak, İ. Köksal, Y. Taşova, V. Korten, G. Yılmaz, M. Çelen, S. Altın, I. Çelik, Y. Bayındır, I. Karaoğlan, A. Yılmaz, A. Özkul, Hazal Gür, S. Unal, Bircan İmran Ayça Ömer Güle İrem Ahmet Çağkan Mehtap Hati Kayaaslan Hasanoğlu Dalkıran Aydos Çınar Akdemir-K, B. Kayaaslan, İ. Hasanoğlu, A. Dalkiran, Ömer Aydos, G. Cınar, Irem Akdemir-Kalkan, A. Inkaya, M. Aydın, H. Çakir, J. Yıldız, Özenir Kocabıyık, S. Arslan, Bayram Nallı, Ömer Demir, Sarp Singil, C. Ataman-Hatipoglu, Gunay Tuncer-Ertem, S. Kınıklı, U. Önal, B. Mete, Gözde Dalgan, M. Taşbakan, T. Yamazhan, B. Kömürcüoğlu, E. Yalnız, Aysun Benli, Çağla Keskin-Sarıtaş, M. G. Ertosun, Özlenen Özkan, S. Emre, S. Arıca, Ferit Kuşçu, A. Candevir, Buket Ertürk-Şengel, Fadime Ayvaz, F. Aksoy, Ç. Mermutluoğlu, Yakup Demir, Gülşah Günlüoğlu, Seda Tural-Önür, Ayşin Kılıç-Toker, E. Eren, B. Otlu, A. Mete, Kübra Koçak, H. Ateş, İlkay Koca-Kalkan, K. Aksu   +76 more
semanticscholar   +1 more source

VACCINATION AND VACCINATION MARKS. [PDF]

The Lancet, 1898
n ...
openaire   +1 more source

Vaccines and Vaccination: The Principles and the Polemics

Journal of Feline Medicine and Surgery, 2009
Background The European Advisory Board on Cat Diseases (ABCD) is a body of experts that sees its task as bringing feline health issues to the forefront of companion animal practice. By way of an introduction to this special ‘clinical practice’ issue of the Journal of Feline Medicine and Surgery (JFMS), this article attempts a ...
Horzinek, M. C., Thiry, Etienne
openaire   +3 more sources